I never knew such exists but going through your write up today, I am glad and more informed
Conclusions In conclusion, the findings from this study underscore the potential of GE2 treatment as a promising therapeutic approach for reducing body weight, visceral fat, and inflammation in the dorsal and ventral hippocampus, as well as the amygdala, depending on sex and diet, while increasing neurogenesis and associative memory
I tredje delen av Nyhetskolls sportserie "S blev jag proffs" hngde vr reporter Louise Mode med 15-riga Alexander Andersson en dag i somras, tog reda p hans framgngsrecept och blickade framt mot en frsta allsvensk ssong med proffskontrakt i Djurgrden.Mer om programmet Hur r det att vara yngst i Allsvenskan
Other research highlights: 30% of GLP-1 users tested positive for SIBO or IMO even after accounting for diabetes (5) GLP-1 medicines caused microbiome changes and altered metabolism in mice (6) GLP-1 medicines tested in humans only had noticeable microbiome changes by 48 weeks (7) Despite not necessarily having slower gut motility, one study found that 88.9% of obese patients had SIBO (8) A meta analysis of people with IBS symptoms, found that up to 78% of people had SIBO, many of whom were undiagnosed (9) Overall, Sun and colleagues (1) could not prove a mechanistic link between GLP-1 medications and SIBO, however they did find that SIBO was twice as likely in GLP-1 users
